The CCL5/CCR5 axis promotes interleukin‐6 production in human synovial fibroblasts

E-ISSN： 1529-0131|62|12|3615-3624

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3615-3624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting CCL5 in inflammation

By Marques Rafael Elias Guabiraba Rodrigo Russo Remo Castro Teixeira Mauro Martins

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1439-1460

Informa Healthcare

Access to resources Recommend Favorite

CCR5 antagonists for the treatment of HIV

By Schmitz Jens

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 277-282

Govi-Verlag

Access to resources Recommend Favorite

The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 76-110

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Intervention at CCR1 and CCR5 as an Approach for Cancer: Help or Hindrance

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1553-1573

Bentham Science Publishers

Access to resources Recommend Favorite

A dual CCR2/CCR5 chemokine antagonist, BMS-813160?

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1919-1924

Informa Healthcare

Access to resources Recommend Favorite